| Primary |
| Drug Use For Unknown Indication |
18.2% |
| Hypertension |
13.1% |
| Thrombosis Prophylaxis |
11.7% |
| Cerebral Infarction |
8.7% |
| Acute Myocardial Infarction |
8.4% |
| Angina Pectoris |
8.1% |
| Diabetes Mellitus |
5.6% |
| Myocardial Infarction |
5.3% |
| Gastric Ulcer |
3.4% |
| Hyperlipidaemia |
3.1% |
| Insomnia |
2.2% |
| Transient Ischaemic Attack |
2.2% |
| Gastritis |
2.0% |
| Osteoporosis |
1.7% |
| Coronary Arterial Stent Insertion |
1.4% |
| Reflux Oesophagitis |
1.4% |
| Constipation |
1.1% |
| Embolic Cerebral Infarction |
1.1% |
| Depression |
0.8% |
| Arteriosclerosis Obliterans |
0.6% |
|
| Pyrexia |
18.8% |
| Interstitial Lung Disease |
11.3% |
| Liver Disorder |
10.0% |
| Thrombotic Thrombocytopenic Purpura |
10.0% |
| Urticaria |
5.0% |
| Vomiting |
5.0% |
| Malaise |
3.8% |
| Pneumocystis Jiroveci Pneumonia |
3.8% |
| Rash Pruritic |
3.8% |
| Respiratory Failure |
3.8% |
| Drug Eruption |
2.5% |
| Hepatic Failure |
2.5% |
| Hepatitis Cholestatic |
2.5% |
| Hepatocellular Damage |
2.5% |
| Loss Of Consciousness |
2.5% |
| Lymphocyte Stimulation Test Positive |
2.5% |
| Nasopharyngitis |
2.5% |
| Nausea |
2.5% |
| Neutropenia |
2.5% |
| Pulmonary Alveolar Haemorrhage |
2.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.2% |
| Hypertension |
15.7% |
| Angina Pectoris |
10.1% |
| Myocardial Infarction |
8.4% |
| Thrombosis Prophylaxis |
5.4% |
| Acute Myocardial Infarction |
5.3% |
| Diabetes Mellitus |
5.2% |
| Prophylaxis |
4.5% |
| Stent Placement |
3.8% |
| Hyperlipidaemia |
3.7% |
| Gastritis |
2.4% |
| Gastric Ulcer |
2.1% |
| Hypercholesterolaemia |
2.1% |
| Percutaneous Coronary Intervention |
2.0% |
| Cardiac Failure |
1.9% |
| Renal Transplant |
1.9% |
| Gastric Ulcer Haemorrhage |
1.7% |
| Cerebral Infarction |
1.5% |
| Sepsis |
1.5% |
| Benign Prostatic Hyperplasia |
1.4% |
|
| Liver Disorder |
22.7% |
| Hepatic Function Abnormal |
11.9% |
| Interstitial Lung Disease |
9.7% |
| Acute Generalised Exanthematous Pustulosis |
6.3% |
| Pyrexia |
5.7% |
| Hepatitis Cholestatic |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| White Blood Cell Count Increased |
4.0% |
| Cerebral Haemorrhage |
3.4% |
| Malaise |
3.4% |
| Sepsis |
3.4% |
| Medication Error |
2.8% |
| Renal Impairment |
2.8% |
| Lymphocyte Stimulation Test Positive |
2.3% |
| Platelet Count Decreased |
2.3% |
| Pneumonia |
2.3% |
| Renal Failure |
2.3% |
| Urine Output Decreased |
2.3% |
| Anaemia |
1.7% |
| Drug Eruption |
1.7% |
|
| Concomitant |
| Hypertension |
30.0% |
| Drug Use For Unknown Indication |
11.0% |
| Angina Pectoris |
7.2% |
| Prophylaxis |
6.2% |
| Cerebral Infarction |
5.5% |
| Diabetes Mellitus |
5.4% |
| Rheumatoid Arthritis |
4.4% |
| Product Used For Unknown Indication |
4.2% |
| Hyperlipidaemia |
3.3% |
| Herpes Zoster |
3.1% |
| Insomnia |
2.6% |
| Gastritis |
2.2% |
| Myocardial Infarction |
2.1% |
| Hypercholesterolaemia |
2.1% |
| Constipation |
2.0% |
| Thrombosis Prophylaxis |
1.9% |
| Cardiac Failure |
1.7% |
| Renal Failure Chronic |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Gastric Ulcer |
1.6% |
|
| Hypoglycaemia |
10.5% |
| Vomiting |
9.7% |
| Pyrexia |
5.6% |
| Renal Impairment |
5.6% |
| Interstitial Lung Disease |
5.2% |
| Pneumonia |
5.2% |
| Rhabdomyolysis |
5.2% |
| Cerebral Infarction |
4.8% |
| Myocardial Infarction |
4.8% |
| Rash |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Liver Function Test Abnormal |
4.4% |
| Respiratory Failure |
4.4% |
| Hepatic Function Abnormal |
4.0% |
| Cardiac Failure |
3.6% |
| Death |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Hypersomnia |
3.2% |
| Platelet Count Decreased |
3.2% |
| Sepsis |
3.2% |
|
| Interacting |
| Hypertension |
33.3% |
| Arteritis Obliterans |
11.1% |
| Cerebral Infarction |
11.1% |
| Diabetes Mellitus |
11.1% |
| Lipid Metabolism Disorder |
11.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.1% |
| Wound Infection |
11.1% |
|
| Ventricular Tachycardia |
100.0% |
|
